Abstract
Hypokinetic dysarthria, a motor speech disorder characterized by reduced movement and control in the speech-related muscles, is mostly associated with Parkinson’s disease. Acoustic speech features thus offer the potential for early digital biomarkers to diagnose and monitor the progression of this disease. However, the influence of language on the successful classification of healthy and dysarthric speech remains crucial. This paper explores the analysis of acoustic speech features, both established and newly proposed, in a multilingual context to support the diagnosis of PD. The study aims to identify language-independent and highly discriminative digital speech biomarkers using statistical analysis and machine learning techniques. The study analyzes thirty-three acoustic features extracted from Czech, American, Israeli, Columbian, and Italian PD patients, as well as healthy controls. The analysis employs correlation and statistical tests, descriptive statistics, and the XGBoost classifier. Feature importances and Shapley values are used to provide explanations for the classification results. The study reveals that the most discriminative features, with reduced language dependence, are those measuring the prominence of the second formant, monopitch, and the frequency of pauses during text reading. Classification accuracies range from 67 % to 85 %, depending on the language. This paper introduces the concept of language robustness as a desirable quality in digital speech biomarkers, ensuring consistent behaviour across languages. By leveraging this concept and employing additional metrics, the study proposes several language-independent digital speech biomarkers with high discrimination power for diagnosing PD.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Czech Ministry of Health under grant no. NU20-04-00294, by EU - Next Generation EU (project no. LX22NPO5107 (MEYS)), and by the European Union's Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement no. 734718 (CoBeN).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Research Ethics Committee (REC) of Masaryk University chaired by prof. RNDr. Renata Veselska, Ph.D., M.Sc. gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Partial Spearman's correlations with 'language' set as a covariate to evaluate relationships between speech and clinical data (Table 5).
